Circle Pharma Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, has appointed Rob Lauzen as Chief Financial Officer. Lauzen brings financial expertise and extensive experience within the life sciences industry, having most recently served as Chief Financial Officer of Prilenia Therapeutics, where he oversaw all aspects of the company’s capital strategy, finance, and investor relations functions. “We are thrilled to welc...